logo
15:43 Dec 05

Sakar Healthcare Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
375.90
-9.65 (-2.50%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Sakar Healthcare Ltd. Financials

Sakar Healthcare Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
375.90
-9.65 (-2.50%)
15:43 Dec 05
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

61/100
Technically Moderately Bullish

Strength

4

Weakness

5

Opportunity

1

Threats

0

6.13 %

ROE %

4.21 %

ROA %

8.77

EPS

130.06

BVPS

9.85 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
128.23 133.36 153.35 177.58 189.18
Operating Expenses +
98.9 100.21 114.99 127.91 137.5
Raw Material
0 0 0 0 101.73
Increase Decrease in Cost
0.93 -0.36 -1.38 -13.2 -12.57
Other Manufacturing Expense
73.49 73.9 85.05 95.47 0
Employee Cost
15.22 16.77 19.78 31.65 33.82
Miscellaneous Expenses
9.26 9.9 11.54 13.99 14.52
Operating Profit
29.33 33.15 38.36 49.67 51.68
Other Income
2.17 4.67 3.18 1.31 1.24
Depreciation
9.67 14.99 18.05 20.88 21.4
Interest
2.9 5.95 7.59 8.53 9.27
Profit before tax and exceptio..
18.93 16.88 15.9 21.58 22.25
Exceptional Items
0 0 0 -0.05 -0.05
PBT
18.93 16.88 15.9 21.53 22.3
Provision for Taxation
3.75 4.12 4.23 4.03 2.44
Net Profit
15.18 12.76 11.67 17.5 19.76
NET Profit after MI
15.18 12.76 11.67 17.5 19.76
EPS
8.73 6.75 5.63 7.95 9.02
Operating Profit Margin (%)
22.87 24.86 25.01 27.97 27.32
Net Profit Margin (%)
11.84 9.57 7.61 9.85 10.45

Sakar Healthcare Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 52.90 52.90 53.60 53.60 53.20 53.20
FII 13.30 13.40 13.60 13.60 13.40 13.50
Public 11.40 11.30 11.00 10.80 10.60 10.60
Others 22.40 22.40 21.80 22.00 22.80 22.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: